DEA Audits Following Fentanyl Diversion Lead to $2 Million Settlement by N.H. Medical Center

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

DEA Audits Following Fentanyl Diversion Lead to $2 Million Settlement by N.H. Medical Center

Staff Writers

July 30, 2023 at 18:23:11 ET

A nonprofit medical center in New Hampshire agreed to pay $2 million to resolve allegations that it violated provisions of the Controlled Substances Act (CSA) by failing to keep accurate records of opioids and other controlled substances. According to the DEA, the resolution is one of the largest-ever settlements of drug diversion claims brought against a hospital. The agency state... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

DEA Audits Following Fentanyl Diversion Lead to $2 Million Settlement by N.H. Medical Center

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT